Ketohexokinase (KHK) iRNA compositions and methods of use thereof
US11926832B2 · kind B2 · utility
1Cited by
4References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 2, 2022 |
| Grant date | Mar 12, 2024 |
| Priority date | — |
| Expiry date | Dec 2, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/53
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to RNAi agents, e.g., dsRNA agents, targeting the ketohexokinase (KHK) gene. The invention also relates to methods of using such RNAi agents to inhibit expression of a KHK gene and to methods of treating or preventing a KHK-associated disorder in a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.